Posted by Michael Wonder on 18 Mar 2024
EMA publishes agenda for 18-21 March 2024 CHMP meeting
18 March 2024 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Dantrolene sodium hemiheptahydrate
- Insulin icodec
- Dimethyl fumarate
- Aztreonam with avibactam
- Iptacopan
- Denosumab
- Bevacizumab
- Dopamine hydrochloride
- Omalizumab
